1. Contractors
  2. Simulations Plus Inc

Simulations Plus Inc

Federal contractor · Research and Development in Biotechnology (except Nanobiotechnology)

Simulations Plus has 5 federal contracts of $100,000 or more active since October 2023, with $1.36M obligated, from 4 agencies. 1 is still running, 1 ending within 18 months.

Contracts
5 since FY2024$1,356,513 obligated, contracts of $100,000 or more
Running now
1 contract2 ended in the last 12 months
Biggest customer
Food and Drug Administration$676K on 2 contracts
UEI
MZN6WDBMXN24Unique entity ID in SAM.gov
Source
USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC

Contracts by start year

Obligated so far on contracts active since October 2023, by the fiscal year each started. Fiscal years run Oct 1 to Sep 30.
Show as table
Fiscal yearContracts
FY2020$160,321
FY2021$476,302
FY2022$144,335
FY2026$575,554

Running contracts

Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.

End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.

Who they work for

AgencyAmount
Food and Drug Administration2 contracts$675,891
Office of the Assistant Secretary for Financial Resources1 contract$375,965
Department of the Army1 contract$160,321
Defense Health Agency1 contract$144,335

What they sell

IndustryAmount
Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 · 1 contract$575,554
Software PublishersNAICS 511210 · 3 contracts$404,994
Other Computer Related ServicesNAICS 541519 · 1 contract$375,965

Where the work is

Place of workAmount
Maryland2 contracts$951,519
California3 contracts$404,994

Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at Food and Drug Administration: see the list.

Get new notices like Simulations Plus's work

New contract opportunities under NAICS 541714, research and development in biotechnology (except nanobiotechnology), the morning they appear. Free while in beta.

Free. We use your email only for these alerts and never share it. Privacy